Allied Healthcare: Pharmacy Services

PGY-2 Oncology Program

Program Overview

Stanford Health Care (SHC) is world-renowned for advanced patient care, particularly for the treatment of cancer. SHC is recognized by U.S. News & World Report as one of "America's Best Hospitals," currently on the Best Hospitals Honor Roll for the tenth year in a row and ranked #13 as the Best Hospitals for Cancer. Stanford Cancer Institute has been a National Cancer Institute (NCI) Designated Cancer Center since 2007 and is a National Comprehensive Cancer Network (NCCN) founding member. Annually, there are over 700 accruals to interventional clinical trials and over 250 actively recruiting clinical trials to pioneer new preventative, diagnostic, and treatment strategies.

The Oncology Residency at SHC is a 12-month PGY2 specialty training program that offers extensive hematology and oncology experiences at Stanford Comprehensive Cancer Center. Two applicants are accepted per year.

The program is designed to transition PGY1 residency graduates from general practice to specialized practice focused on the care of patients with oncologic and hematologic disorders. Residency graduates will be equipped to participate as integral members of interdisciplinary teams, assuming full responsibility for optimizing patient care as an oncology pharmacist.

Throughout the program, residents gain practical experience in the management of malignancies as well as cancer-related and cancer treatment-related disorders. In light of the prominent use of investigational drugs in the treatment of cancer, residents acquire the knowledge and skills necessary to practice effectively in clinical research environments. Residents also manage the preparation, distribution, and disposal of hazardous medications in both inpatient and ambulatory settings. Other experiences include oncology administration and leadership, formulary management, teaching and precepting, and research.

Program Mission

The mission of the PGY2 Oncology Residency Program is to provide a broad experience-based foundation in hematology/oncology, develop clinical skills and knowledge in evidence-based medicine, and prepare for a comprehensive practice in hematology/oncology in clinical, administrative, research, and/or academic settings. Upon completion of the residency program, the resident will:

1. Provide optimal clinical care to patients with oncologic and hematologic disorders
2. Function independently as an effective member of the health care team
3. Educate health care professionals, students, patients, and the community about effective and safe medication use
4. Establish a practice change based on a completed research project
5. Develop excellent written and verbal communication skills
6. Demonstrate time management and problem-solving skills
7. Become a leader within the pharmacy profession 

Program Structure

The PGY2 Oncology Specialty Residency is accredited by the American Society of Health System Pharmacists (ASHP). The program follows goals and learning objectives are consistent with standards developed by ASHP.

Longitudinal Experiences

• Outpatient Oncology Clinics (16 weeks in the first half of the year, 20 weeks in the second half of the year)
• Independent research project presented at a national conference
• Residency research seminars
• Active participation in interdisciplinary patient care rounds
• Comprehensive patient care, including patient counseling and education
• Expansion of clinical pharmacist roles and initiation of a new oncology pharmacy-related service
• Education to pharmacy, medical, and nursing staff as well as PGY1 pharmacy residents and students
• Administration projects in the hematology/oncology setting, such as monograph, policy, protocol, and guideline preparation and presentation
• Hematology/oncology medication use evaluation presented to P&T Committee
• Hematology/oncology related committee meetings
• Teaching experiences, including didactic and precepting opportunities
• Journal club and forum presentations, including a CAPE-accredited CE and a clinical debate
• Chemotherapy preparation and dispensing
• Staffing 16 hours every 3 weeks in the inpatient hematology/oncology/BMT pharmacy satellites and outpatient infusion treatment area

Compensation and Benefits

PGY-2 residents receive a competitive annual stipend of approximately $81,000 with full benefits, including an excellent health care benefits package and 10 days paid time off (PTO). In addition, the PGY-2 resident will enjoy educational leave and a stipend to attend and participate at various pharmacy conferences throughout the year.

Eligibility

• Completion of Doctor of Pharmacy degree from an ACPE-accredited school or college of pharmacy
• Completion of an ASHP-accredited PGY1 residency program
• Interview at Stanford Health Care (on-site or virtual depending on the pandemic situation)
• Licensure to practice pharmacy in the state of California prior to October 1
• See Application Process for additional details

Current Residents

Liki Ng, Pharm.D.

Liki received her Bachelor of Science in Biochemistry and Cell Biology from the University of California, San Diego and her Doctor of Pharmacy from the University of California, San Francisco. She completed her PGY-1 Acute Care Pharmacy Residency at Stanford Health Care. Her professional interests include hematologic malignancies, cellular therapy, and immunotherapy. In her free time, Liki enjoys cooking, trying out new restaurants, traveling, snowboarding, and spending quality time with her cavapoo.

Uyen Tran, Pharm.D.

Uyen received her Bachelor of Science in Biochemistry from the University of California, Los Angeles and Doctor of Pharmacy from the University of Washington in Seattle. She completed her PGY1 pharmacy practice residency at UCHealth Memorial Hospital Central in Colorado Springs. Her professional interests include hematology, oncology, bone marrow transplant, and emergency medicine. In her free time, Uyen enjoys doing hot yoga, exploring new coffee shops, hanging out with Baby Blue, and hopefully traveling around the world.